Loading…
Loading…
EQUITY / NASDAQ · XNCM
KORU Medical Systems Inc.
Following is saved. Automatic company research is not available for this coverage; explore the evidence with Research.
No accepted understanding yet. Follow this company to establish research where evidence supports it.
Open research workspace →04/01/2026 – 06/30/2026 · USD · Units
Reported figures establish facts for this period; they do not by themselves establish a profitability trend.
Open report ↗2.98 USD · 0.6757%
Observed: Oct 2, 2026, 10:57 PM · TickerLayer indicative price; may be delayed
Powered by TickerLayer
10/02/2026 · 2.96 USD · Volume 274,898
251 actual observations · Latest bar: 2026-10-02 · Market data is indicative; provider terms apply.
8 available financial reports
Research reports →SEC FINANCIAL REPORTS
04/01/2026 – 06/30/2026 · Units
| Metric | 2026 / Quarter 2 | 2025 / Quarter 2 | Change |
|---|---|---|---|
| Revenue | 12,045,420 USD | 10,194,800 USD | +18.15% |
| Operating profit | 626,991 USD | -312,655 USD | — |
| Net income | 252,449 USD | -206,867 USD | — |
| Cash and cash equivalents | 8,287,704 USD | — | — |
| Total liabilities | 9,910,496 USD | — | — |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2026 / Quarter 204/01/2026 – 06/30/2026ConsolidatedUnits · USD | 2026 / Quarter 201/01/2026 – 06/30/2026ConsolidatedUnits · USD | 2026 / Quarter 201/01/2026 – 03/31/2026ConsolidatedUnits · USD | 2025 / Quarter 212/31/2025 – 12/31/2025ConsolidatedUnits · USD | 2025 / Year end01/01/2025 – 12/31/2025ConsolidatedUnits · USD | 2025 / Quarter 307/01/2025 – 09/30/2025ConsolidatedUnits · USD | 2025 / Quarter 301/01/2025 – 09/30/2025ConsolidatedUnits · USD | 2025 / Quarter 204/01/2025 – 06/30/2025ConsolidatedUnits · USD |
|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalentsBalance sheet | 8,287,704 USD | — | — | 8,872,212 USD | 8,872,212 USD | 8,464,019 USD | — | — |
| Gross profitIncome statement | 7,846,208 USD | 15,077,597 USD | — | — | 25,604,079 USD | 6,264,571 USD | 18,786,676 USD | 6,475,769 USD |
| Net incomeIncome statement | 252,449 USD | -554,629 USD | -807,078 USD | — | -2,637,926 USD | -777,966 USD | -2,151,070 USD | -206,867 USD |
| Operating profitIncome statement | 626,991 USD | -237,933 USD | — | — | -2,972,442 USD | -867,679 USD | -2,425,338 USD | -312,655 USD |
| RevenueIncome statement | 12,045,420 USD | 23,810,044 USD | — | — | 41,127,366 USD | 10,402,163 USD | 30,232,038 USD | 10,194,800 USD |
| Total assetsBalance sheet | 27,962,013 USD | — | — | 28,200,179 USD | 28,200,179 USD | 27,103,526 USD | — | — |
| Total equityBalance sheet | 18,051,517 USD | — | 16,922,354 USD | 17,047,922 USD | 17,047,922 USD | 16,464,825 USD | — | 16,526,374 USD |
| Total liabilitiesBalance sheet | 9,910,496 USD | — | — | 11,152,257 USD | 11,152,257 USD | 10,638,701 USD | — | — |
| Capital expendituresCash flow statement | — | 154,070 USD | — | — | 932,517 USD | — | 524,735 USD | — |
| Financing cash flowCash flow statement | — | -148,032 USD | — | — | -221,350 USD | — | 43,558 USD | — |
| Investing cash flowCash flow statement | — | -667,252 USD | — | — | -949,790 USD | — | -528,135 USD | — |
| Operating cash flowCash flow statement | — | 230,776 USD | — | — | 462,405 USD | — | -632,351 USD | — |
| Report source | Open report ↗ Published: 08/05/2026 | Open report ↗ Published: 08/05/2026 | Open report ↗ Published: 08/05/2026 | Open report ↗ Published: 08/05/2026 | Open report ↗ Published: 03/12/2026 | Open report ↗ Published: 11/12/2025 | Open report ↗ Published: 11/12/2025 | Open report ↗ Published: 08/05/2026 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.